Blood glucose meters
We've consulted on a proposal for five-years' sole supply for CareSens blood glucose and ketone meters and test strips. We're considering the responses.
In 2012 PHARMAC moved to sole supply of blood glucose meters and testing strips, which are mainly used by people with diabetes to test their blood sugar levels. The price reduction from changing to sole supply of the CareSens range of meters and strips meant savings of $10 million per year compared to previous spending, that can be used to fund other medicines.
Summary of responses to consultation
In March 2015 PHARMAC released a consultation document that looked at the future funding approach to blood glucose meters and test strips. The consultation provided information and asked questions to help inform PHARMAC’s approach for the funding of blood glucose meters and test strips.
PHARMAC received 313 individual responses to the consultation from consumers, consumer groups, health professionals and suppliers of blood glucose meters and test strips. People provided us with lots of different feedback and opinions on the questions and proposed approach.
Requests for proposals
We are in the second stage of our procurement process following a release of a Request for Proposals (RFP) in August 2016 to suppliers of meters and test strips. We are currently evaluating the RFP responses.
Until any decisions are made, CareSens meters and tests strips will continue to be funded.
Last updated: 17 October 2017